Work

Avaliação dos efeitos celulares, humorais e moleculares da administração do teduglutide num modelo animal de anastomose intestinal

Year: 2018
Type: dissertation
Abstract: Despite recent progresses in surgical technique and perioperative care, failure of intestinal anastomotic healing remains one of the most feared complications in digestive surgery, exerting a profound adverse impact on the operative morbidity and mortality rates, oncologic, and functional outcomes and socioeconomic costs. Teduglutide is an enterotrophic analogue of glucagon-like peptide 2 (GLP-2) approved for the pharmacological rehabilitation of short-bowel syndrome. Present study aims to clarify the potential of teduglutide as a promoting strategy for the improvement of intestinal anastomotic healing, on an animal model, through the influence on the cellular, humoral and molecular mediators of repair. An experimental rat model of standard small-bowel anastomosis was used with evaluation at the third and seventh postoperative days. Structural assessment of the anastomosis included the macroscopic integrity and the histological and immunohistochemical examination of healing parameters, comprising reepithelialization, neoangiogenesis and fibroplasia. Cellular and molecular mediators of anastomotic healing were analyzed, including: putative epithelial stem cells response (using Lgr5, Bmi1 and the panel CD24/CD44/CD166/Grp78 surface markers by flow cytometry); cellular viability and death (with double staining with annexin-V/propidium iodide by flow cytometry); oxidative stress [quantification of cytosolic peroxides with 2’,7’-dichlorodihydrofluorescein diacetate (DCFH2) probe, mitochondrial reactive species with dihydrorhodamine 123 (DHR 123) probe, total intracellular reduced glutathione with mercury orange staining and mitochondrial membrane potential with 5,5',6,6'-tethrachloro-1,1',3,3'-tethraethylbenzimidazolcarbocyanine iodide (JC-1) probe, by flow cytometry]; local and systemic inflammatory response (tissue and plasma concentrations of interleukine-1α, macrophage chemo-attractant protein-1, tumor necrosis factor-α, interferon-γ and interleukine-4 by flow cytometric multiplexed bead assay); gene expression of main extracellular matrix components (Collagen, type I, alpha 1: Col1a1; Collagen, type III, alpha 1: Col3a1; Collagen, type IV, alpha 1: Col4a1; Collagen, type V, alpha 1: Col5a1) and remodeling factors, matrix metalloproteinases (Mmp; Mmp1 and Mmp13, Mmp2 and Mmp9, Mmp3, Mmp12 and Mmp14) and tissue inhibitors of metalloproteinases 1 and 2 (Timp; Timp1 and Timp2); gene expression of growth factors and receptor potentially implicated on anastomotic repair (Insulin-like growth factor 1, transcript variant: Igf1; Vascular endothelial growth factor A, transcript variant 2: Vegfa; Transforming growth factor, beta 1: Tgfb1; Connective tissue growth factor: Ctgf; Fibroblast growth factor 2: Fgf2; Fibroblast growth factor 7: Fgf7; Epidermal growth factor: Egf; Heparin-binding epidermal-like growth factor: Hbegf; Platelet-derived growth factor beta polypeptide: Pdgfb; Glucagon-like peptide 2 receptor: Glp2r) by quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR); and Glp-2 plasma levels (by competitive enzyme immunoassay). Teduglutide had no apparent relevant impact on the rate or severity of intestinal anastomotic leakage. A favorable influence of teduglutide on the reepithelialization and neoangiogenesis events of the proliferative phase of anastomotic repair was documented. Teduglutide was associated with an increase of subepithelial myofibroblasts density score, but no significant effect on the goblet, Paneth and glial cellular indexes was observed. This growth factor was associated with an enhancement of type III collagen deposition on the submucosa at the seventh postoperative day, although with simultaneous reduction of type I collagen level in that layer, and a non-significant reduction of global anastomotic collagen content. Teduglutide inhibited the gene modulation of fibrolysis in the predominantly inflammatory phase of anastomotic repair, while stimulated the fibrolysis in the proliferative stage. Teduglutide induced the upregulation of gene expression of Timp1, Timp2 and Col4a1, and the downregulation of Mmp3 and Mmp12, at the third postoperative day; and the repression of gene expression of Timp1, Col3a1, Col4a1 and Col5a1, at the seventh day. Teduglutide contributed to the expansion of the putative crypt base columnar stem cells pool at the seventh day and to the concomitant depletion of the putative “position +4” stem cells fraction. An increase (non-significant) of the overall putative intestinal epithelial stem cells was also observed in teduglutide-treated animals. Teduglutide was associated with a non-significant prooxidative effect, with an increase of the cytosolic peroxides level and mitochondrial reactive species levels and a reduction of the cellular reduced glutathione content. Those effects were coincident with an increase of cellular viability indexes and a non-significant decrease of early apoptotic events. No relevant influence on mitochondrial membrane potential was verified. A non-significant increase of tissue levels of the anti-inflammatory interleukin-4 at the seventh day, and a significant reduction of plasma levels of interferon-γ at the third day were observed in teduglutide-treated animals. Teduglutide induced the upregulation of the gene expression of Igf1, Vegfa and Ctgf and the downmodulation of Fgf2, Fgf7, Tgfb1 and Glp2r. To conclude, the present study reflects the complexity of the intestinal anastomotic repair and points to a favorable influence of teduglutide on this process that deserves additional investigation.
Language: Portuguese
Subfield: Surgery
Field: Medicine
Open Access status: green
OpenAlex ID: W2894322418
Cites: 342
Cited by:
Related to: 10